Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1
- PMID: 16386314
- DOI: 10.1016/j.imlet.2005.11.003
Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1
Abstract
In the in vitro infected B-cells six EBV-encoded nuclear antigens (EBNA-1-6) and three latent membrane proteins (LMP-1, -2A, -2B) are expressed (type III latency). In addition, other restricted forms of latency occur in the EBV-carrying malignancies. In Burkitt lymphoma (BL) only EBNA-1 is expressed (type I), while in Hodgkin lymphoma (HL), T-, and NK-lymphoma, and nasopharyngeal carcinoma EBNA-1 and LMPs are expressed (type II). B-cells with these three expression patterns have been detected in healthy virus carriers. While in type III latency two viral transcriptional activators, EBNA-2 and -5, are responsible for LMP-1 expression, the mechanism that controls the expression of LMP-1 in type II latent cells is not known. In order to study the interaction of EBV- and HL-derived cells, we studied the in vitro EBV-converted subline of the KMH2 cells that express only EBNA-1 and LMP-2A. Interestingly, exposure of the KMH2-EBV cells to CD40-ligand and IL-4 induced LMP-1 expression, in the absence of EBNA-2. In BL cell lines lacking EBNA-2 another cytokine, IL-10, could induce LMP-1 expression. IL-10 induced LMP-1 also in tonsillar B-cells infected with the EBNA-2-deleted virus strain P3HR-1. Our results show that cytokines are responsible for the expression of LMP-1 in type II latent B-cells. These signals are available in the germinal center environment and in the granulation tissue of HLs. Based on these results we propose that LMP-1 expression is induced by extracellular signals and is not a constitutive characteristic of the EBV-carrying type II B-cells. Cytokine mediated induction of LMP-1 may also explain the heterogeneous expression of this viral gene seen in normal and malignant cells.
Similar articles
-
Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.J Immunol Methods. 2012 Nov 30;385(1-2):60-70. doi: 10.1016/j.jim.2012.08.008. Epub 2012 Aug 18. J Immunol Methods. 2012. PMID: 22921685
-
IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines.Blood. 2006 Apr 1;107(7):2928-35. doi: 10.1182/blood-2005-06-2569. Epub 2005 Dec 6. Blood. 2006. PMID: 16332968
-
Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.J Med Virol. 2001 Sep;65(1):114-20. J Med Virol. 2001. PMID: 11505452
-
T cell recognition of Epstein-Barr virus associated lymphomas.Cancer Surv. 1992;13:53-80. Cancer Surv. 1992. PMID: 1330300 Review.
-
EBV-B cell interactions: immortalization, rescue from apoptosis, tumorigenicity (a short review).Acta Microbiol Immunol Hung. 1996;43(2-3):97-105. Acta Microbiol Immunol Hung. 1996. PMID: 8876725 Review.
Cited by
-
Infectious mononucleosis mimicking Epstein-Barr virus positive diffuse large B-cell lymphoma not otherwise specified.Int J Hematol Oncol. 2020 Jul 17;9(2):IJH25. doi: 10.2217/ijh-2020-0002. Int J Hematol Oncol. 2020. PMID: 33005328 Free PMC article.
-
Treatment Advances in EBV Related Lymphoproliferative Diseases.Front Oncol. 2022 Apr 19;12:838817. doi: 10.3389/fonc.2022.838817. eCollection 2022. Front Oncol. 2022. PMID: 35515118 Free PMC article. Review.
-
The vIL-10 gene of the Epstein-Barr virus (EBV) is conserved in a stable manner except for a few point mutations in various EBV isolates.Virus Genes. 2007 Dec;35(3):563-9. doi: 10.1007/s11262-007-0153-5. Epub 2007 Aug 31. Virus Genes. 2007. PMID: 17763933
-
Epstein-Barr virus-associated lymphoid malignancies: the expanding spectrum of hematopoietic neoplasms.Nagoya J Med Sci. 2013 Aug;75(3-4):169-79. Nagoya J Med Sci. 2013. PMID: 24640173 Free PMC article. Review.
-
Genetic variability and mutation of Epstein‒Barr virus (EBV)-encoded LMP-1 and BHRF-1 genes in EBV-infected patients: identification of precise targets for development of personalized EBV vaccines.Virus Genes. 2023 Aug;59(4):541-553. doi: 10.1007/s11262-023-02006-x. Epub 2023 May 27. Virus Genes. 2023. PMID: 37243920 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials